AzTrials
AzTrials

Obtaining OCT (Optical Coherence Tomography) ImagesNCT07584798

Self-Monitoring OCT

A study testing Self-administered OCT imaging system and Technician-acquired OCT imaging in people with Obtaining OCT (Optical Coherence Tomography) Images, run by Case Western Reserve University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record

Search all trials

Trial summary

The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Self-administered OCT imaging system and Technician-acquired OCT imaging
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited States
Study dates
Sep 2026to 15 Dec 2027
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 1. Provision of signed and dated informed consent.
  • 2. Age ≥ 18 years.
  • 3. Presenting for care at a University Hospitals Eye Institute clinic
  • 4. Willing to complete study questionnaires.
  • 5. Scheduled to undergo standard technician-acquired OCT

Who cannot join

  • 1. Unable to provide informed consent or, in the judgment of study staff, unable to understand study procedures.
  • 2. Unable to cooperate with imaging or maintain stable positioning such that an evaluable OCT scan cannot be obtained (e.g., severe tremor or inability to maintain head position).
  • 3. Facial skin condition or open wound at the points of device contact that would make use of the headrest unsafe.
  • 4. Acute medical or ocular condition requiring immediate evaluation that, in the PI's judgment, precludes participation at that time.
  • 5. Any other condition that, in the opinion of the PI/designee, would place the participant at undue risk or compromise data quality (documented).
  • 6. Patients with visual acuity <20/200.
  • 7. Patients with significant media opacities precluding an OCT scan (posterior subcapsular cataract, vitreous hemorrhage, etc), or severe ptosis.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106

    Warren Sobol, MD

Other trials in United States

About this study

Official title: Self-Monitoring Optical Coherence Tomography Device for Retinal Telehealth

The purpose of this research study is to test participants ability to obtain OCT images of the eyes using an OCT device that is comparable to FDA-approved OCT devices on the market, without the help of an eye technician. Patients with ocular diseases often need to come to frequent appointments with an eye care provider for close monitoring and evaluation. Transportation difficulties, other medical problems, and limited appointments slots can make regular follow-up challenging. In addition, the anxiety of permanent vision loss and subjective nature of monitoring symptoms highlight the need for an alternative solution in which patients can self-generate OCT images of the eye for the eye care provider to review.

Being tested
Self-administered OCT imaging system, Technician-acquired OCT imaging
Keywords
Ocular diseases, Eye care provider, Self monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-administered OCT imaging systemProcedure or surgery

    Self-administered OCT imaging using modified portable OCT with headrest and software workflow to enable patient self-operation and secure image transfer to a remote reading center.

  • Technician-acquired OCT imagingProcedure or surgery

    Technician-acquired OCT obtained using routine clinical equipment during the same visit

Study groups in NCT07584798
Study groupRoleWhat they receive
Self-administered OCT ImagesExperimentalParticipants will use an OCT device to obtain OCT images of the eyes.
Receives: Procedure: Self-administered OCT imaging system
Technician-acquired OCTActive comparatorTechnicians will use a standard OCT device to obtain OCT images of the eyes as per standard of care.
Receives: Procedure: Technician-acquired OCT imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of inner retinal abnormalities detected as measured by OCT images

    Measured: through study completion, an average of 1 year

  2. Number of outer retinal abnormalities detected as measured by OCT images.

    Measured: through study completion, an average of 1 year

  3. Sensitivity as measured by OCT images.

    Measured: through study completion, an average of 1 year

  4. Specificity as measured by OCT images.

    Measured: through study completion, an average of 1 year

  5. Positive predictive value (PPV) as measured by OCT images.

    Measured: through study completion, an average of 1 year

  6. Negative predictive value (NPV) as measured by OCT images.

    Measured: through study completion, an average of 1 year

Secondary outcomes (3)
  1. Image-quality as recorded by nurse coordinator during patient interaction with the device.

    Measured: through study completion, an average of 1 year

  2. Number of successful completion of self-scans as recorded by nurse coordinator during patient interaction with the device.

    Measured: through study completion, an average of 1 year

  3. Number of repeated attempts

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 May 2026
  2. Study startSep 2026 (estimated)
  3. Primary completion15 Dec 2027 (estimated)
  4. Study completion15 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07584798
Sponsor's protocol ID
STUDY20211004
Status last verified
Sep 2026
First submitted
7 May 2026
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in